Mirvetuximab (M9346A) (powder) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab (powder) is the antibody moiety of folate receptor alpha (FRalpha)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRalpha-positive cancer research[1][2][3].
Molecular Weight:
(145.2 kDa)
Purity:
99.31
CAS Number:
[1453084-36-0]
Target:
ADC Antibody,Antifolate
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted